CBRE - CBRE Group, Inc.
NYSE
->
Real Estate
->
Real Estate Services
Dallas,
United States
Type: Equity
CBRE price evolution
CBRE
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1033 | $1127 | $1371 | |
| Short term investments | ||||
| Net receivables | $8796 | $7277 | $7020 | $7045 |
| Inventory | ||||
| Total current assets | $10616 | $9653 | $9444 | $9666 |
| Long term investments | $1309 | $1298 | $1374 | |
| Property, plant & equipment | $2289 | $1927 | $1903 | $1937 |
| Goodwill & intangible assets | $8052 | $7852 | $7210 | |
| Total noncurrent assets | $13809 | $13520 | $12882 | |
| Total investments | $1309 | $1298 | $1374 | |
| Total assets | $24845 | $23462 | $22964 | $22548 |
| Current liabilities | ||||
| Accounts payable | $3851 | $3568 | $3415 | $3562 |
| Deferred revenue | $311 | $304 | $298 | |
| Short long term debt | $2180 | $1934 | $933 | |
| Total current liabilities | $9430 | $8629 | $8233 | $8243 |
| Long term debt | $3365 | $4363 | $4337 | $3893 |
| Total noncurrent liabilities | $5644 | $5632 | $5238 | |
| Total debt | $6543 | $6271 | $4826 | |
| Total liabilities | $16153 | $14273 | $13865 | $13481 |
| Shareholders' equity | ||||
| Retained earnings | $9584 | $9384 | $9263 | $9188 |
| Other shareholder equity | -$895 | -$1031 | -$1005 | -$924 |
| Total shareholder equity | $8356 | $8261 | $8267 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1371 | $1404.85 | $2539.78 | $2039.25 |
| Short term investments | ||||
| Net receivables | $7045 | $6255.31 | $6454.19 | $5806.12 |
| Inventory | $193.33 | $96.24 | $55 | |
| Total current assets | $9666 | $8528.68 | $10082.36 | $8845.63 |
| Long term investments | $1374 | $1317.7 | $1196.09 | $854.87 |
| Property, plant & equipment | $1937 | $1960.08 | $1862.47 | $1835.36 |
| Goodwill & intangible assets | $7210 | $7061.09 | $7404.6 | $5189.52 |
| Total noncurrent assets | $12882 | $11984.71 | $11991.13 | $9193.51 |
| Total investments | $1374 | $1317.7 | $1196.09 | $854.87 |
| Total assets | $22548 | $20513.39 | $22073.49 | $18039.14 |
| Current liabilities | ||||
| Accounts payable | $3562 | $3078.78 | $2916.33 | $2692.94 |
| Deferred revenue | $298 | $276.33 | $280.66 | $162.04 |
| Short long term debt | $933 | $1326.14 | $1542.54 | $1599.33 |
| Total current liabilities | $8243 | $8241.99 | $8418.87 | $7143.98 |
| Long term debt | $3893 | $1143.81 | $2654.68 | $2497 |
| Total noncurrent liabilities | $5238 | $3665.66 | $4295.51 | $3389.5 |
| Total debt | $4826 | $3492.23 | $4197.23 | $4096.33 |
| Total liabilities | $13481 | $12660.12 | $12714.37 | $10533.48 |
| Shareholders' equity | ||||
| Retained earnings | $9188 | $8832.94 | $8366.63 | $6530.06 |
| Other shareholder equity | -$924 | -$982.78 | -$640.66 | -$529.73 |
| Total shareholder equity | $8267 | $7853.27 | $8528.19 | $7078.33 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $9036 | $8391 | $7935 | $8949.98 |
| Cost of revenue | $6793 | $6475 | $7092.27 | |
| Gross Profit | $1795.6 | $1598 | $1460 | $1857.71 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1191 | $1111 | $1206.24 | |
| Total operating expenses | $1369.5 | $1352 | $1269 | $1363.2 |
| Operating income | $246 | $191 | $494.5 | |
| Income from continuing operations | ||||
| EBIT | $225 | $133 | $652.56 | |
| Income tax expense | $67 | $32 | -$29 | $136.01 |
| Interest expense | -$68 | $63 | $36 | $39.4 |
| Net income | ||||
| Net income | $225 | $130 | $126 | $477.15 |
| Income (for common shares) | $130 | $126 | $477.15 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $31949 | $30828.25 | $23826.19 | |
| Cost of revenue | $25675 | $24239.49 | $19047.62 | |
| Gross Profit | $6274 | $6588.76 | $4778.57 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $4562 | $4649.46 | $3306.2 | |
| Total operating expenses | $5184 | $5321.26 | $3896.61 | |
| Operating income | $1090 | $1267.5 | $881.97 | |
| Income from continuing operations | ||||
| EBIT | $1385 | $1710.6 | $1033.84 | |
| Income tax expense | $250 | $234.23 | $214.1 | |
| Interest expense | $149 | $69 | $67.75 | |
| Net income | ||||
| Net income | $986 | $1407.37 | $751.99 | |
| Income (for common shares) | $986 | $1407.37 | $751.99 | |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $130 | $126 | $477.15 | |
| Operating activities | ||||
| Depreciation | $161 | $158 | $156.96 | |
| Business acquisitions & disposals | -$306 | -$789 | -$28.25 | |
| Stock-based compensation | $39 | $30 | $22.98 | |
| Total cash flows from operations | $287 | -$492 | $853.38 | |
| Investing activities | ||||
| Capital expenditures | -$144 | -$127 | -$161.48 | |
| Investments | ||||
| Total cash flows from investing | -$1494 | -$407 | -$900 | -$143.87 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$47 | -$19.13 | ||
| Net borrowings | $130 | $1317 | -$661.97 | |
| Total cash flows from financing | $927 | $50 | $1192 | -$752.32 |
| Effect of exchange rate | -$15 | -$24 | -$44 | $60.6 |
| Change in cash and equivalents | -$214 | -$94 | -$244 | $17.79 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $986 | $1407.37 | $1836.57 | $751.99 |
| Operating activities | ||||
| Depreciation | $622 | $613.09 | $525.87 | $501.73 |
| Business acquisitions & disposals | -$276 | -$572.3 | -$1260.18 | -$85.53 |
| Stock-based compensation | $96 | $160.32 | $184.93 | $60.39 |
| Total cash flows from operations | $480 | $1629.09 | $2364.18 | $1830.78 |
| Investing activities | ||||
| Capital expenditures | -$476 | -$260.14 | -$209.85 | -$266.57 |
| Investments | $212.72 | |||
| Total cash flows from investing | -$681 | -$832.46 | -$1280.9 | -$341.58 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$665 | -$1850.32 | -$368.6 | -$50.03 |
| Net borrowings | $1141 | $189.54 | $187.82 | -$433.8 |
| Total cash flows from financing | $154 | -$1766.09 | -$490.63 | -$625.26 |
| Effect of exchange rate | $13 | -$165.47 | -$92.12 | $81.56 |
| Change in cash and equivalents | -$34 | -$1134.93 | $500.53 | $945.5 |
News
|
Year in Review: A timeline of 2024 - Pittsburgh Business Times
The Business Journals
31 Dec 2024
|
|
Zacks Industry Outlook Howard Hughes, Green Brick Partners and LGI Homes
Zacks · via Yahoo Finance
30 Dec 2024
|
|
CBRE Group, Inc. (NYSE:CBRE) Receives $133.33 Consensus PT from Analysts
ETF DAILY NEWS
30 Dec 2024
|
|
3 Real Estate Stocks to Buy as Mortgage Rates Continue to Rise
Zacks · via Yahoo Finance
30 Dec 2024
|
|
CBRE Group, Inc. (NYSE:CBRE) Shares Sold by JPMorgan Chase & Co.
ETF DAILY NEWS
29 Dec 2024
|
|
Creative Capital, Partnerships Loom Large in Healthcare Real Estate, Says...
REBusinessOnline.com
20 Dec 2024
|
|
Here’s Why CBRE Group (CBRE) Surged in Q3
Insider Monkey · via Yahoo Finance
20 Dec 2024
|
|
Director of the Year Recipients Announced by NADC NJ Chapter
New Jersey Business Magazine
19 Dec 2024
|
|
CBRE Group (NYSE:CBRE) Raised to “Overweight” at JPMorgan Chase & Co.
ETF DAILY NEWS
17 Dec 2024
|
|
3 Allspring Mutual Fund for Consistent Returns
Zacks · via Yahoo Finance
17 Dec 2024
|
Fundamentals
| Market cap | $37.84B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 306.01M |
| Revenue | $34.31B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $958.15M |
| Revenue Q/Q | 14.84% |
| Revenue Y/Y | 10.00% |
| P/E ratio | 39.50 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.10 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $3.13 |
|---|---|
| ROA | 4.09% |
| ROE | N/A |
| Debt/Equity | 1.63 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.13 |
| Quick ratio | N/A |